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ABSTRACT
Peptide hormones are important biomolecules that transduce downstream effects such as cell
proliferation, regulation, and gene expression. Their levels have been upregulated in various
disorders such as cancer, yet detection methods are lacking. We designed two split aptamerbased assays for the detection of a peptide hormone – Somatostatin (SST) – with different
signal readouts: fluorescent readout based on label-free light-up aptamers and the colorimetric
readout based a G-quadruplex peroxidase-like deoxyribozyme. We used an already selected
split-aptamer –SSTA5–for SST for our designs and we had expected the developed detection
systems to exhibit detection and quantification capabilities that would hopefully allow their use
for SST monitoring in clinical samples. However, our experiments have revealed that neither the
designed split chimera constructs nor the previously reported split SST-specific aptamer system
bind the peptide hormone. To determine if the split SSTA5 aptamer could bind SST
appropriately, Förster resonance energy transfer (FRET) was used. We verified that there was
no energy transfer between the two fluorophores attached to each part of the split SSTA5
aptamer. As a result of the lack of split SSTA5 binding to either SST-14 or SST-28, no SST
detection was achieved using either fluorescent or colorimetric methods. Therefore, careful
analysis of a functionally active SSTA5 split system, or selection of another, more appropriate,
aptamer for SST, will be needed for further aptameric-based detection methods. Once this is
accomplished, our methodologies could be re-applied for detection of SST, which could lead to
real-time detection of essential hormonal levels in patients.
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INTRODUCTION
Functions of Somatostatin
Two forms of Somatostatin (SST) exist: one is a cyclic tetradecapeptide with an amino acid
sequence: Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys 1 (Scheme 1A); the other
form has 28 amino acids with a sequence of: Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-GluArg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys.2 Both are biologically active
and share common effects but differ in their potency.3 They are specifically known for their
inhibitory effects when bound to its corresponding G-protein coupled receptors.4,5 In the
hypothalamus, SST is produced and released to travel to the anterior pituitary through the
hypophyseal portal system to inhibit the release of Growth Hormone,6 Thyroid-stimulating
hormone or Prolactin7. In addition, there are other regions which are modulated by SST, such as
the arcuate nucleus,8 the hippocampus,9 and the brain stem of the solitary tract.10

Beyond the brain, SST is secreted by delta cells in the stomach, intestine, and pancreas.11 In
these areas, it effectively slows down digestion by lowering the production of HCl from parietal
cells,12 prevents the release of gastrin, secretin, and histamine,13 and modulates the secretion
of insulin and glucagon in the pancreas. Furthermore, the SST released from the stomach can
travel through the portal vein system to the heart and to show systemic effects.
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It was proposed that SST may have a role in controlling cellular proliferation through its
secondary messenger system.14 Plasmatic SST has been upregulated in a number of
physiological disorders, such as schizophrenia15 and cancer.16,17 In a study of meningiomas,
there was a total increase of SST receptors of all the investigated samples using receptor
autoradiography.17 Overall, peptide hormones like SST hold important roles for homeostasis
and should be monitored closely to determine ailments.18

Current Detection Methods
Although the functions of peptide hormones are important, few tools have been developed for
their detection. Currently, liquid chromatography/mass spectrometry (HPLC/MS) can be used
for the sensing of peptides,19,20 or through antibody-based analysis of patient samples.21

Antibody-based detection of Peptides
When an antigen is injected in a living organism, the animal’s immune system will elicit a
response to produce antibodies against it. These antibodies will have high specificity to
epitopes on the target and can be used effectively for detection when run with Enzyme-Linked
Immunosorbent Assay (ELISA). When using ELISA, the potential antigens of a sample are
attached to a solid support, and a known antibody (primary antibody) is added to bind its target
antigen in the sample. This antibody, or a secondary antibody, is linked to an enzyme for
fluorescent or colorimetric detection based on the catalytic action of the attached enzyme.
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When the substrate of the enzyme is added, a measurable readout will be produced if the
antigen of interest is present in the sample. 22

The in vivo antibodies used in ELISA first need to be identified and purified before detection of a
target can be performed. Today, many companies have already identified many antibodies that
can bind targets of interest, like SST, which are commercially available. However, there are
limitations when using ELISA: the antibodies need to be conjugated with an enzyme, and such a
modification can impair the functions of either of the conjugated components, or both; and
there is a high cost associated with the purchase of antibodies. The price is partially due to the
extensive effort of maintaining the quality of products during the scaling-up process and
limiting potential viral or bacterial contamination.

In addition, when working with antibodies, special care needs to be taken, since they can
undergo irreversible denaturation when subject to varying environmental factors. Therefore,
antibody-based tests are often require cold storage and shipping conditions. To be able to
detect SST in a more user-friendly way, preferably at the point-of-care or at even home, new
diagnostics assays utilizing stable components and easy-to-use reporting systems are needed.

Aptamers
Aptamers, an invented Latin term that means ‘to fit’, are composed of synthetic single-stranded
RNA (ssRNA) or DNA (ssDNA) sequences, which can form higher-ordered secondary and tertiary
3

structures to create a target-binding pocket. A growing interest in the use of aptamer
technology is currently being explored for biosensing capabilities.23,24 The folding patterns of
aptamers can confer functional properties like antibodies to specific substrates in a “lock-andkey” fashion.25 A functional aptamer ranges in size from ~20-100nt, which is about 20-25-fold
smaller (in mass) than monoclonal antibody analogs.26

Advantages of Aptamers
The synthesis of nucleic acids for aptamers hold a number of advantages over antibody
counterparts. When the sequence is known, the production of an aptamer can be done much
more rapidly than the production of antibodies. Antibodies require the immune response
against an antigen, which can take days to weeks; whereas in vitro synthesis of aptamers can be
done in minutes due to the advances in automatic oligonucleotide synthesis capabilities.

Since aptamers are produced chemically, they are less prone to be contaminated with viral or
bacterial components than antibodies, and they can be conjugated to functional groups or dyes
during synthesis for detection techniques. In addition, nucleic acid sequences are much more
stable to the environmental factors and cheaper than antibodies.

Aptamer Selection
Aptamers that bind a target of interest are usually selected through Systematic Evolution of
Ligands by Exponential Enrichment (SELEX). To perform this technique, a large combinatorial
4

library composed of single stranded nucleic acid (~1014 different sequences) is run through an
affinity column containing a protein/peptide or small molecule target of interest (Figure 1).

The single stranded nucleic acids have unique conformations due to differences in their
nucleotide sequences; these conformations allow for varying degrees of binding to the target.
When the library is incubated with the target of interest, the nucleic acids that have a high
affinity will be able to be separated from other sequences in the library. The bound sequences
can then be removed from the target and amplified by Polymerase Chain Reaction (PCR) to
create a secondary, enriched, library of less complexity. This enriched library will be used in the
subsequent rounds of selection. After each round, nucleic acids with increasing affinities stay
bound to the target, whereas ones that can bind to the target only weakly are eluted away.
After 8-12 rounds of selection, the selected ligands are sequenced and evaluated for their
affinity for the targeted protein.

5

Figure 1: SELEX
Single stranded nucleic acids have unique conformations due to differences in their nucleotide sequences; these
conformations allow for varying degrees of binding to a target molecule. When a DNA/RNA library (~1014 different
sequences) is incubated with the target of interest, the nucleic acids that have a high affinity will be able can be
separated from other sequences in the library. The bound sequences (in the binding fraction) can then be removed
from the target and amplified by Polymerase Chain Reaction (PCR) to create a secondary, enriched, library of less
complexity. This enriched library will be used in the subsequent rounds of selection (~8-12 rounds). After each
round, nucleic acids with increasing affinities stay bound to the target, whereas ones that can bind to the target
only weakly are eluted away. After all weak-bounded nucleic acids are eluted away, the selected ligands can be
sequenced and evaluated for their affinity for the targeted protein.

Aptamer for Somatostatin (SSTA5)
The aptamer toward SST was selected by Takenaka et. al.27 through SELEX. After determining
the DNA aptamer with the highest specificity to SST, named SSTA5, they further split it between
nucleotides 42 and 43 (split aptamer shown in Scheme 1B).28 It was mentioned that it was split
in this location because it separated the longest base pairs and appropriately maintained the
6

bulge loop between A42 and T59. The split the aptamer was further applied for detection of SST
using Atomic Force Microscopy (AFM) for a signal readout.26

AFM uses a probe (cantilever) to survey a sample and make a topographical image that
simultaneously detects an interactive force via a system of force-distance measurements.29 The
5’-end of the split aptamer strand SSTA5-5) was chemically modified with a biotin group to
interact with a streptavidin molecule attached to the cantilever, and the 3’-end of the split
aptamer strand SSTA5-3) modified with a biotin group was attached to a gold chip surface. In
the presence of the hormone target, the two strands re-associated into the aptamer-SST
tripartite complex to bring the cantilever close to the chip surface, which could be measured by
AFM.29 Although AFM allowed for sensitive and selective detection of SST, the technique is not
user-friendly and limits the usage to labs with proper equipment.
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Scheme 1: SST-14 and Split SSTA5
A: Primary structure of SST-14, a cyclic tetradecapeptide with an amino acid sequence: Ala-Gly-Cys-Lys-Asn-PhePhe-Trp-Lys-Thr-Phe-Thr-Ser-Cys. B: Aptamer for SST, SSTA5, that was isolated and split (between nucleotides 42
and 43) by Takenaka et. al27,28 to create two strands of the split aptamer - SSTA5-5 (Magenta) and SSTA5-3 (light
blue). Proposed nucleotide binding was rendered using NuPACK30 at 25°C.

Since the various antibody-based detection methods have been proven to have their respective
obstacles, we tried to overcome them by building on split SSTA5 for more user-friendly sensors.
As mentioned previously, DNA aptamers are advantageous tools to use for their affordability,
versatility, and stability.
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MATERIALS AND METHODS
All oligonucleotides were purchased from Integrated DNA Technologies, Inc. (Coralville, IA).
Somatostatin was purchased from Sigma-Aldrich. Their concentrations were calculated from
their measured absorbances with Thermo Scientific NanoDrop OneC, prior to experimentation
using Equation 1. The extinction coefficient (ε) for SST was calculated using Equation 2.

Auramine-O dye and the components of reaction buffer 1 (Tris-HCl, KCl, and MgCl2) were all
purchased from Sigma-Aldrich. Fluorescence data was recorded using Cary Eclipse fluorescence
spectrometer (Agilent). The excitation wavelength was set to 390 nm and the emission was
taken at 505 nm. DAP-10 (Table 1) was used as a positive control.

To test if the strands GUS1-5 and GUS1-3 assemble into the structure containing a parallel Gquadruplex, we used a thioflavin dye that is known to bind to the G-quadruplex structure.
Thioflavin T was purchased from Sigma-Aldrich (St. Louis, MO). It was added to the samples
containing GUS1-5 and GUS1-3 as an additional buffer component. The fluorescence of
thioflavin-T containing samples at 490 nm was measured using a Cary Eclipse fluorescence
spectrometer (Agilent) upon excitation at 412 nm. The components of reaction buffer 2
(HEPES·NaOH, MgCl2, KCl, NaCl, Dimethyl Sulfide (DMSO), and Triton X-100) were also
purchased from Sigma–Aldrich. PW17 (Table 1) was used as a positive control.
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Covalently-attached fluorophores (Table 1) to SSTA5 were ordered from Integrated DNA
Technologies, Inc. (Coralville, IA). FRET was ran in Reaction buffer 1 (described above) to help
stabilize the hybridization of the arms together in the presence of SST.

Fluorescence data for FRET assay was recorded using Cary Eclipse fluorescence spectrometer
(Agilent). The excitation wavelength was set to 485 nm and the emission was measured at 520
and 580nm.

A 10% polyacrylamide gel was prepared using Acrylamide/bisacrylamine (AABA) and N,N,N′,N′tetramethylethylene-diamine (TEMED) purchased from Bio-Rad, Ammonium persulfate (APS)
purchased from Sigma-Aldrich, and Tris-borate-EDTA (TBE) purchased from Thermo Fischer.
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METHODOLOGY
Hypothesis
We proposed to explore two different reporting systems as a signal readout for the SST-specific
split-aptamer sensor. For both of them, we built on the split SST-aptamer designed by Takenaka
et al.28 (Scheme 1B). All referenced designs with their respective nucleotide sequences can be
referred in Table 1 in the appendix.

Detection Technique 1, Fluorescence of Auramine-O
Our first approach uses a label-free light-up methodology to turn on the fluorescence of
Auramine-O dye (Scheme 2A), which, like dapoxyl dye, usually does not fluorescence but can
become highly fluorescent in certain organic solvents,31 or when activated with binding to a
specific DNA aptamer (Scheme 2D). An example of an aptamer, which makes Auramine-O
fluorescent is DAP-10, which was isolated by Kato et. al 32 and then split by Kikuchi et. al. 33 Both
research groups used these aptamers in combination with a fluorogenic dye; dapoxyl sulfonic
acid (DSA). However, DSA is not commercially available, which makes it more complicated and
expensive to use it in biosensor development. At the same time, it has been recently discovered
in our laboratory that DSA-specific aptamer DAP-10 can also bind and trigger the increase in
fluorescence of a commercially available triarylmethane dye Auramine-O (data not shown),
which we employed in this project.
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When designing our sensor, we preserved the sequence of original dye-binding portion of the
split aptamer provided by Kikuchi et. al33, which we fused, via a short stem, with the split SSTA5
aptamer from 26, so that the 5’-end of the SSTA5-5 sequence was connected to the shorter
fragment of the split DAP-10 aptamer, and the 3’-end of the SST5-3 strand was fused with the
longer fragment of the split DAP-10 aptamer (Scheme 2C). In addition, to add to the flexibility
for both aptamer cores to assemble, we added a dithymidilate bridge (TT) on both sides. The
split dapoxyl aptamer (SDA) previously reported33 was initially used to report the presence of a
specific nucleic acid. Here, we are using the methodology for the detection of a peptide
hormone target, SST, instead of a nucleic acid target (Scheme 2D). The use of Auramine-O dye
offers many advantages for a biosensor development. For example, the free dye has a very low
fluorescent background, which allows for very high signal to background ratio and a low limit of
detection. The fluorescence increase can be observed as fast as the complex between the
aptamer and the dye is formed, which allows for rapid instantaneous target monitoring. Finally,
the dye can bind to the aptamer-based biosensor non-covalently without the need to conjugate
one or more sensor component with a fluorescent tag, which decreases the cost and
complexity of the bioanalytical assay.
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Scheme 2: Detection Technique 1, Fluoresence of Auramine-O
A: Structure of Auramine-O dye. B: DAP-10 split-sequence provided by Kikuchi et. al.33 C: proposed binding of
strands DAPS1-3 and DAPS1-5 at 25°C using NuPACK30. The purple shading represents the original SSTA5 splitsequence and the orange shading represents the original DAP-10 split-sequence used to construct DAPS1-3 and
DAPS1-5 D: Proposed mechanism of binding of the biosensor’s strands DAPS1-3 and DAPS1-5 in the presence of
SST (brown octagon) and Auramine-O dye (yellow circle). Once all the components have come together, the
Auramine-O dye is expected to become highly fluorescent, which is represented by the yellow sun. Since this
assembling is believed to be triggered by the presence of SST, the designed construct is proposed for SST
detection.
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Detection technique 2, Fluoresence of Formation of G-Quadruplex
Our second approach is colorimetric detection of SST through the peroxidase function of a Gquadruplex(G4)-hemin complex. In a G4 structure, four guanine bases associated together
through Hoogsteen hydrogen bonding34 to form a square planar structure that is stabilized by
cations, such as K+.35

When stabilized, parallel G4 structures catalyze the peroxidation of a colorless organic
compound into a colored product. We proposed to design a split aptamer with a G4-hemin
signal reporter: an asymmetrically split G4 with one G-triplet on one strand and three G-triplets
on the other strand (Scheme 3A), according to the guidelines previously developed in our lab.36
The designed constructs contained strands GUS1-3 and GUS1-5. GUS1-3 was constructed from
SSTA5-3 with the addition of three G triplets (TGGGTTGGGTTGGGT). GUS1-5 was constructed
from SSTA5-5 with the addition of one G triplet(TGGGT). We specifically designed these two
strands in this way because there was a known G-rich region on SSTA5-5, thus by only adding
one G-rich region, instead of three onto GUS1-5, we would limit the possibility forming an
unwarranted G4-structure with only the GUS1-5 strand. In our work for the initial testing of the
sequences, we used a fluorogenic dye Thioflavin-T, which is known to bind to G4 structures
and, therefore, can indicate the expected complexation of the designed strands in the presence
of SST (Scheme 3B).37
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Scheme 3: Detection Technique 2, Fluorescence of Formation of G-Quadruplex
A: Proposed binding of the two strands GUS1-3 and GUS1-5 using NuPACK30 at 25°C to form an asymmetrically split
G-quadruplex (G4) with one G-triplet on one strand (GUS1-5) and three G-triplets on the other strand (GUS1-3).
The purple shading represents the original split-sequence from SSTA5 and the orange region represents the G4forming region of GUS1-3 and GUS1-5. B: Illustration of mechanism behind G4 formation for detection of SST. The
two arms GUS1-5 and GUS1-3 become associated together in the presence of SST to form an asymmetrical parallel
G4. Thioflavin-T becomes fluorescent in the presence of a G4 structure (shown by green product) which can allow
for detection of SST by measuring fluorescence.

Concepts For the Two Detection Methods
For two outlined approaches above (fluorescent and colorimetric), we expected a high signal to
be generated only in the presence of SST, when two signal reporter subunits are brought
together as a result of the hormone binding to the split SST aptamer. The presence of the SST
hormone would, therefore, be reported by the increase of fluorescence (first approach), which
would be measured using a portable fluorometer, or by a color change upon formation of G4
15

peroxidase-like deoxyribozyme (second approach). A color change can be visually observed, as
well as quantified by measuring the absorbance of the sample at 420 nm (if ABTS is used as a
colorogenic substrate) using a UV-Vis spectrophotometer.36

FRET
To test the ability of the two strands constituting the split-SSTA5 aptamer (SSTA5-3 and SSTA55) to associate in the presence of SST, we used Förster resonance energy transfer (FRET), which
is a mechanism used to determine if two fluorophores are within a close distance of each other.

In using FRET, a fluorescent donor is excited at is specific fluorescence excitation wavelength.
This excitation energy is then transferred to a second molecule, the acceptor, by a long-range
dipole–dipole coupling mechanism, while the donor returns to the electronic ground state. The
acceptor emits the transferred energy at higher wavelength, which can be detected using a
fluorometer.38

We added two fluorophores to each arm of the SSTA5 aptamer (Table 1). 6-FAM: an amine
derivative of fluorescein (FAM) fluorophore, was added to the 5’-end of the SSTA5-5 strand and
named FAM-SSTA5-5. Tetramethylrhodamine (TAMRA), a fluorophore that can serve as an
acceptor of FAM fluorescence and thereby constitutes a suitable FRET partner for FAM, was
covalently attached to the 3’-end of the SSTA5-3 aptamer strand and named TAMRA-SSTA5-3.
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The peak absorbance wavelength for 6-FAM is 487 nanometers (nm) with a peak emission
wavelength at 520 nm (Figure 2). The peak absorbance wavelength of TAMRA is 552nm with a
peak emission wavelength of 580nm (Figure 2). TAMRA and FAM are a FRET pair because the
emission for FAM overlaps excitation for TAMRA, shown in Figure 2. If the two fluorophores are
not in proximity of each other, excitation at 485 nm will result in emission at 520 nm, with
TAMRA not excited, so that the ratio F580/F520 is low. If 6-FAM and TAMRA are brought in
proximity, and they are excited at 485 nm, the emission will be at 580 nm, with the decrease in
the FAM emission at 520 nm, due to 6-FAM transferring its energy to TAMRA. As a
consequence, the higher is the concentration of the complex between the two fluorophorecontaining oligonucleotides, the higher ratio F580/F520 is expected.

Figure 2: Spectra of FAM and TAMRA
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The excitation plot of FAM is shown by the dashed-blue line with a peak absorbance wavelength at 487
nanometers (nm). The emission plot of FAM is shown by a solid blue line with a peak emission wavelength at 520
nm. The excitation plot of TAMRA is shown by the dashed-orange line with a peak absorbance wavelength at
552nm. The emission plot of TAMRA is shown by a solid blue line with a peak emission wavelength at 580 nm.
TAMRA and FAM are a FRET pair because the emission for FAM overlaps excitation for TAMRA

Based on the reported re-formation of the SST5A split into SST5-5 and SST5-3 in the presence of
SST,26 we expected that the two fluorophores could be brought in proximity by the addition of
SST (Scheme 1B), and the FRET would be observed. We expected the FRET signal (F580/520) to
increase with the concentration of SST added.

For this purpose, we excited the solution containing both FAM-SST5-5 and TAMRA-SST5-3 at
485nm and scanned the emission 500-580nm with recording measurements at 520 and 580nm.
Close interaction between the two arms of the aptamer in the presence of SST would cause a
more pronounced energy transfer, which could be measurable on the fluorimeter at 580nm.
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RESULTS AND DISCUSSION
Design of the split aptameric chimeras for SST detection
We proposed to explore a split aptamer technology and develop two split aptamer-based
assays for the detection of SST. One of the assay involves a fluorescent readout based on lightup DAP-10 aptamer in complex with a fluorogenic dye Auramine O. Another assay offers a
colorimetric readout due to the peroxidation of a colorless organic substrate (e.g. ABTS) into a
colored product catalyzed by G-quadruplex(G4)-hemin complex formation upon SST binding
and bringing the two halves of the split G4-sequences. For both assays, we built on the split
SST-aptamer designed by Takenaka et al.28 (Scheme 1B). The sequence of SSTA5 was split
between nucleotides 42 and 43, according to the design previously utilized for AFM-assisted
SST detection.26 The signal generating sequences – either of DAP-10 or G4-forming – were
added to each of the strands constituting the split SSTA5 to extend beyond the splitting site
(Table 1). We hypothesized that binding of SST by the re-formed aptameric core of SSTA would
bring in proximity the signal generating aptameric “halves”, and either Auramine O binding to
yield increase in fluorescence or formation of a G4-quadruplex promoting the peroxidation
reaction can be achieved to report the presence of SST. We expected the developed detection
systems to exhibit detection and quantification capabilities that would allow their use for SST
monitoring in samples. However, the results of this project does not support that hypothesis.
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Detection Technique 1
First, we tested the constructs consisting of DAPS1-5 and DAPS1-3 strands (Table 1). The
samples containing Auramine O and the two strands (1µM) were mixed in buffer 1 in the
absence of SST or in the presence of SST-14 (0.1µM or 1µM). To ensure that that under the
conditions used, the fluorescence of Auramine O could be turned on by DAP-10, a positive
control containing the dye mixed in the same buffer with DAP-10 (1µM) was used. Figure 3
demonstrates the data in signal-to-background (S/B) calculated by dividing the relative
fluorescent units (RFU) of each sample by the background fluorescence of reaction buffer 1 .
Based on these results, there was no significant difference between the values of the samples
in the absence of SST-14 or the presence of two different SST-14 concentrations. On the other
hand, the positive control, DAP-10 (1µM), was able to produce a signal to background value of
about 140. Therefore it can be concluded that detection technique 1 was not able to produce a
fluorescent read-out in the presence of SST-14.
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Fluoresence of Auramine-O, DAPS1(1µM), and SST-14(XµM)
160

Signal/Background
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Figure 3: Fluoresence of Auramine-O Results with SST-14
All samples were incubated for one hour at 22°C in reaction buffer 1 and 20µM Auramine-O. Blue: the
signal/background value of the 1µM DAPS arms with no SST-14. Orange: The signal/background value of the 1µM
DAPS arms with 0.1µM SST-14. Grey: The signal/background value of the 1µM DAPS arms with 1µM SST-14.
Yellow: The signal/background value of the positive control (PC), 1µM DAP-10.

It should be noted that in the original publications reporting isolation, splitting and detection of
SST with SSTA5,27,28 the authors did not specify which of the two SST forms they used.
Therefore, we decided to test another SST – SST28. The experimental set-up was similar to the
experiment illustrated in Figure 3. The fluorescence of five samples were measured at 22°C in
reaction buffer 1 supplemented with 25µM Auramine-O: DAPS1-5 and DAPS1-3 (each at 1µM)
in the absence of SST-28 or in the presence of increasing concentrations of SST-28 (0.2µM,
1µM, 5µM or 25µM) (Figure 4). Only one trial was performed with these samples, thus no
standard deviation is shown. Based on these results, there was no significant difference in21

between the fluorescence triggered by the aptameric construct in the absence or presence of
SST-28 either.

Fluoresence of Auramine-O, DAPS1(1µM) + SST-28(XµM)
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Figure 4: Fluoresence of Auramine-O Results with SST-28
All samples were incubated for one hour at 22°C in reaction buffer 1 and 25µM Auramine-O. The samples were
measured by dividing the relative fluorescent intensities (RFU) by the intensity of the buffer supplemented with
Auramine-O (signal/background). Dark Blue: the signal/background value of the 1µM DAPS1 arms with no SST-28.
Orange: The signal/background value of the 1µM DAPS arms with 0.2µM SST-28. Grey: The signal/background
value of the 1µM DAPS arms with 1µM SST-28. Yellow: The signal/background value of the 1µM DAPS arms with
5µM SST-28. Light blue: The signal/background value of the 1µM DAPS arms with 25µM SST-28.

Detection Technique 2
Discouraged by the results obtained for the fluorescence-based sensor design, we then
proceeded with testing on the split chimera design relying of the G4 formation. Generally, the
G4 structures are very stable under proper conditions, so we hoped that this construct had
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more chances to properly fold into both the SSTA5 core and G4 structure as triggered by SST
presence. To simplify testing, we did not perform the peroxidation reaction to monitor the
color change signaling of the G4 formation, but instead used a fluorogenic dye; Thioflavin T. It is
known that G4 structures have affinity to Thioflavin T, and the dye-G4 interactions increase the
fluorescence of the dye. Therefore, we measured fluorescence of Thioflavin T for the samples
containing the strands GUS 1-5 and GUS 1-3 (1µM each) in the absence or presence of various
concentrations of SST-14 (0.01 µM, 0.1 µM, or 1 µM). As positive control of G4 formation a
sequence of the peroxidase-like deoxyribozyme PW17 (1µM) was used. From the data shown in
Figure 5, It can be seen that while PW17 successfully formed the G4 structure and bounds the
dye to increase its fluorescence, the fluorescence of Thioflavin T mixed with GUS1-3 and GUS 15 was not affected by the presence of SST-14. Therefore, we confirmed that under the
conditions used, the G4 structure could be potentially formed, but the designed chimera cannot
detect SST-14.
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Fluoresence of Formation of G-Quadruplex with SST-14
80
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Figure 5: Fluoresence of the Formation of G-Quadruplex results
All samples were incubated for one hour at 22°C in reaction buffer 2 and 2µM Thioflavin-T (TFT). Dark blue: the
Relative Fluorescent Units (RFU) of the 1µM GUS1 arms (GUS1-3 and GUS1-5) with no SST-14. Orange: The RFU of
the 1µM GUS1 arms with 0.01µM SST-14. Grey: The RFU of the 1.0µM GUS1 arms with 0.1µM SST-14. Yellow: The
RFU of the 1.0µM GUS1 arms with 1.0µM SST-14. Light blue: The RFU of the positive control (PC), 1µM PW-17.

FRET
Taking into account the negative results obtained for aptameric chimer designs, we decided to
test the assembly of the split SSTA5 in the presence of SST-14 or SST-28. For this purpose, we
equipped the strands SSTA5-5 and SSTA5-3 with FAM and TAMRA fluorophores, respectively
(Table 1). These dyes serve as a FRET pair (Figure 2), so if the SSTA5 core is reformed in the
presence of the hormone, the fluorophores will be brought in proximity, which would generate
FRET. We first tested if FAM-SSTA5-3 at the increasing concentrations preserves the same FRET
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ratio (FI(580)/FI(520)). FAM has a maximal emission at 520 nm upon the fluorophore’s
excitation at 485 nm. As the concentration of the FAM-labeled strand increases, it is expected
that the intensity of fluorescence emission at both 520 nm (maximum) and 580 nm (shoulder or
slope of the emission peak) increases (Figure 2), but the ratio should be constant. As can be
seen from the data on Figure 6, the ratio stayed constant despite the increase of fluorescence
at both 520 nm and 580 nm with the increase of FAM-SSTA5-3 concentration.

FRET: FAM-SSTA5-3
0.2
0.18

FI(580)/FI(520)

0.16
0.14
0.12
0.1
0.08
0.06
0.04
0.02
0

0.1

0.2
0.5
[FAM-SSTA5-3] (µM)

1.0

Figure 6: Constant FI(580)/FI(520) for increased concentrations of FAM-SSTA5-3
The samples presented are measured in the quotient of their measured fluorescent intensity (FI) at wavelength of
580nm by the measured FI of sample at 520nm [(FI(580)/FI(520)]. Each bar has corresponding colors and
concentrations of the FAM SSTA5-3 strand: Dark blue, 0µM (blank); orange, 0.1µM; grey, 0.2µM; yellow, 0.5µM;
light blue, 1µM.
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Figure 7 shows the data of the dependence of the FRET efficiency on the presence of SST-14.
We varied the concentrations of strands FAM-SSTA5-5 and TAMRA-SSTA5-3 (0.1, 0.2, 0.5, or
1µM each), while keeping the SST-14 at 0.5 µM. In can be seen, that the FRET intensity was not
significantly affected for all the strand concentrations tested, which can be interpreted as the
lack of binding between the two strands of the SSTA5 aptamer and the SST-14 target. It should
be noted though that the strands most likely associate with each other in the absence of the
hormone, since the FRET intensity for the mixture of FAM-SSTA5-5 and TAMRA-SSTA5-3 was
about 4-fold higher than that for just FAM-SSTA5-5 present (compare data in Figure 6 and
Figure 7).

Comparison of SSTA5 Interaction with and without SST-14
0.7

FI(580)/FI(520)
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[FAM-SSTA5-3, TAMRA-SSTA5-5] (µM)

Figure 7: FRET TAMRA-SSTA5-5 and FAM-SSTA5-3
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The samples presented are measured in the quotient of their measured fluorescent intensity (FI) at wavelength of
580nm by the measured FI of sample at 520nm [(FI(580)/FI(520)]. Two series are used for comparison for
interaction of SSTA5 with and without SST-14. Each series contains the two fluorescently-labeled strands of SSTA5:
FAM-SSTA5-3 and TAMRA-SSTA5-5. Series 1 (grey) measures the interaction between the two strands without SST14; series 2 (blue) measures the interaction between the two strands with 0.5µM SST-14. Each series has
corresponding concentrations of both the TAMRA SSTA5-5 and FAM SSTA5-3 strands: 0.1µM, 0.2µM, 0.5µM, and
1µM SSTA5 strands.

We next tested the binding of SST-28 to the FRET-labeled strands of the split SSTA5 in a similar
manner (Figure 8 and Figure 9). For this experiment, we varied the concentration of both the
aptamer strands (0.5µM or 1µM) and the hormone added (0, 0.2, 1, 5, or 25µM). No increase
in FRET intensity was observed in the presence of increasing concentrations of SST-28 at any of
the strand concentrations used, thus indicating the lack of binding of the split aptamer to SST28 as well.
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Figure 8: FRET TAMRA-SST 5-5(0.5µM), FAM-SST 5-3(0.5µM), and SST-28(XµM)
The samples presented are measured in the quotient of their measured fluorescent intensity (FI) at wavelength of
580nm by the measured FI of sample at 520nm [(FI(580)/FI(520)]. Each sample contained 0.5µM of both TAMRASSTA5-5 and FAM-SSTA5-3 strands. The bars presented have corresponding colors to the concentrations of SST-28:
Dark blue, 0µM SST-28 arms; orange, 0.2µM SST-28; grey, 1µM SST-28; yellow, 5µM SST-28; light blue, 25µM SST28.

FI(580)/FI(520)

FRET: TAMRA-SSTA5-5(1µM), FAM-SSTA5-3(1µM),
and SST-28(XµM)
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Figure 9: FRET of TAMRA-SSTA5-5(1µM), FAM-SSTA5-3(1µM), and SST-28(XµM)
The samples presented are measured in the quotient of their measured fluorescent intensity (FI) at wavelength of
580nm by the measured FI of sample at 520nm [(FI(580)/FI(520)]. Each sample contained 0.5µM of both TAMRASSTA5-5 and FAM-SSTA5-3 strands. The bars presented have corresponding colors to the concentrations of SST-28:
Dark blue, 0µM SST-28 arms; orange, 0.2µM SST-28; grey, 1µM SST-28; yellow, 5µM SST-28; light blue, 25µM SST28.
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Gel Electrophoresis:
The absence of the complex between the two strands of the split SST aptamer and SST-14 was
confirmed by the gel shift assay. We used native polyacrylamide gel electrophoresis (PAGE) to
monitor the association of the strands constituting split SSTA5 with each other in the absence
or presence of SST-14. In PAGE performed under native conditions, molecules are allowed to
stay in their native state and thus are separated based on charge, shape, and size.

We have analyzed the samples containing each of the two strands alone (TAMRA-SSTA5-3 or
FAM-SSTA5-5, each at 0.5µM), both strands together in the absence of the peptide hormone,
and both strands in the presence of different SST-14 concentrations (1µM, 10µM, or 20µM). As
a control, SST-14 alone was used. The gel was ran at 50V for 4 hours in a cold room with
temperature set at 0°C to preserve the interactions between the complex components, if any.
The bands were visualized after staining with GelRed, and the gel image was taken using a
BioRad Gel Documentation XR System.

If the two pieces hybridized (FAM-SSTA5-3 and TAMRA-SSTA5-5), there would only be one
corresponding band of about 100 nucleotides instead of two bands of 42 and 53 in the lanes
which contained both arms and SST.

We used seven lanes to prepare this gel (Figure 10): M, a nucleotide ladder with lengths of (10,
20, 30, 40, 50, and 60); Lane 1, 0.5µM TAMRA-SSTA5-3; Lane 2, 0.5µM FAM-SSTA5-5; Lane 3,
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0.5µM TAMRA-SSTA5-3 and 0.5µM FAM-SSTA5-5; Lane 4, 0.5µM TAMRA-SSTA5-3, 0.5µM FAMSSTA5-5, and 1.0µM SST-14; Lane 5, 0.5µM TAMRA-SSTA5-3, 0.5µM FAM-SSTA5-5, and 10.0µM
SST-14; Lane 6, 0.5µM TAMRA-SSTA5-3, 0.5µM FAM-SSTA5-5, and 20.0µM SST-14; Lane 7,
20.0µM SST-14.

One significant observation is the second, slow-migrated band in lane 2. It was expected that
there would be only one band present in this lane at the weight of FAM-SSTA5-5, about 42
nucleotides. However, since there are two bands present, it can be assumed that SSTA5-5 has
significant secondary structure which is prohibiting its migration in the gel. Indeed, at 4 oc,
computer-based prediction (by NUPACK software) indicate a rather stable intermolecular stemloop structure with the free energy of -12.35 kcal/mol (Figure 11A). Due to the intramolecular
complementarity, a dimer of SST5-5 characterized by a free energy of -34.53 kcal/mol (Figure
11B) is possible. Neither of the two structures would, however, migrate that slowly in gel.
Anyway, the alternative low-mobility structure may prevent the strand from interacting with
SST5-3 and/or the peptide hormone.

Since there are two bands present in lanes 4, 5, 6 and each one correspond to either SSTA5-3 or
SSTA5-5, it can be concluded that they do not interact together or in the presence of SST. If the
arms (TAMRA-SSTA 5-3 and FAM-SST-5 ) were able to hybridize in the presence of SST, only one
band would be seen in the lanes that contained both arms and SST (lanes 4, 5, 6) whereas two
bands would be seen in lane 3 since it has 0µM SST-14.
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Figure 10: Gel Shift Assay
M: Nucleotide ladder, bands correspond to nucleotide lengths of (10, 20, 30, 40, 50, and 60). 1: 0.5µM TAMRA-SST
5-3. 2: 0.5µM FAM-SST 5-5. 3: 0.5µM TAMRA-SST 5-3 and 0.5µM FAM-SST 5-5. 4: 0.5µM TAMRA-SST 5-3, 0.5µM
FAM-SST 5-5, and 1.0µM SST-14. 5: 0.5µM TAMRA-SST 5-3, 0.5µM FAM-SST 5-5, and 10.0µM SST-14. 6: 0.5µM
TAMRA-SST 5-3, 0.5µM FAM-SST 5-5, and 20.0µM SST-14. 7: 20µM SST-14.
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Figure 11: Possible Secondary Structure and Dimer of SSTA5-5 at 4°C
A: Computer-based prediction (by NUPACK software30) indicate a rather stable intermolecular stem-loop structure
of SSTA5-5 at 4°C with the free energy of -12.35 kcal/mol. B: Computer-based predication (by NUPACK30) of a
possible SSTA5-5 dimer due to the intramolecular complementarity at 4°C with a free energy of -34.53 kcal/mol.
Note: purple and green coloring are arbitrary, the strands are both SSTA5-5 (table 1).
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FUTURE DIRECTIONS
Investigation and optimization of our assay components with SSTA5 are needed to determine if
the efficiency of SST detection can be improved with our presented assays. Currently, we might
be lacking a vital buffer component, which would cause inappropriate interaction between the
SSTA5 aptamer and SST. Therefore introducing other salts or compounds could enhance the
overall systems.

In addition, other designs can be constructed using truncated-SSTA5 sequences as a
foundation. Removal of nucleotides in SSTA5-5 might weaken the formation of an unwarranted
secondary structure (the possible hairpin loop or dimerization, Figure 11) and thus enhancing
the interaction with SST.

Furthermore, selection of another, more appropriate, aptamer for SST, might be needed for
enhanced SST detection. SELEX can be used with another library of DNA sequences to find other
potential aptamers for SST. These can be analyzed to find their interaction capabilities with SST.
The ones with lower dissociation constant values can be built on with our current detection
methodologies for potential SST monitoring.
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CONCLUSION
We designed two chimera constructs consisting of two split aptamers fused together. In both
constructs, a split aptamer towards a peptide hormone –somatostatin– was expected to reform
its binding pocket and bind the hormone target, which would bring in proximity the fragment of
another aptamer which expected to serve as a signal reporter. Each construct had a different
signal reporter. One contained fragments of a light-up DAP-10 aptamer, which is known to bind
and thereby turn-on the fluorescence of a fluorogenic dye; Auramine O. In this design, the
presence of SST would be detected through an increase in fluorescence of Auromine O, which
was expected to depend on the concentration of the peptide. Another construct contained the
sequences of split SSTA5 fused with G-rich fragments, which were thought to fold into a Gquadruplex peroxidase-like deoxyribozyme upon binding of SST to the construct. When
complexed with hemin, the G-quadruplex peroxidase-like deoxyribozyme is known to catalyze
peroxidation of a colorless organic molecule (e.g., ABTS) into a colored product, thus enabling
SST detection with a color change as a signal readout. In our work we used Thioflavin-T as a
well-known ligand for G-quadruplex structures. However, our experiments have revealed that
neither the designed split chimera constructs nor the previously reported split SST-specific
aptamer system bind the peptide hormone. To determine if the split SSTA5 aptamer could bind
SST appropriately, Förster resonance energy transfer (FRET) was used. We verified that there
was no energy transfer between the two fluorophores attached to each part of the split SSTA5
aptamer. As a result of the lack of split SSTA5 binding to either SST-14 or SST-28, no SST
detection was achieved using either fluorescent or colorimetric methods. Therefore, careful
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analysis of SSTA5 to find a functionally active split aptamer system, or selection of another,
more appropriate, aptamer for SST, will be needed to further explore a promising aptamerbased strategy for somatostatin monitoring. Once this is accomplished, our methodologies
could be re-evaluated for detection of SST, which could lead to real-time detection of essential
hormonal levels in patients.
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EQUATIONS
𝛢𝛢 = 𝜀𝜀𝑐𝑐𝑐𝑐

Equation 1 Beer-Lambert Equation: used to find the concentration of SST using the Absorbance
(A), the extinction coefficient (ε) and path length of light (l).

𝜀𝜀280=𝑛𝑛𝑛𝑛(5500)+𝑛𝑛𝑛𝑛(1490)+𝑛𝑛𝑛𝑛(200)

Equation 2 Calculating the Extinction Coefficient (ε): using the amino acid composition of SST.
N is the number of moles found of each specific amino acid residue: Tryptophan (W), Tyrosine
(Y), and Phenylalanine (F).
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APPENDIX: NUCLEOTIDE SEQUENCES
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Table 1: Nucleotide Sequences

A: The nucleotide sequence of SSTA5, the original unsplit SST aptamer discovered by Takenaka et. Al. B-E: The light
blue represents the original 3’ side of SSTA5, named SSTA5-3, and the magenta colored nucleotides are from the
original 5’ side of SSTA5, named SSTA5-5. B: Split SSTA5. B1: Nucleotides in SSTA5-5. B2: Nucleotides in SSTA5-3. CE: bold/underlined nucleotides are additions to the split SSTA5 used for detection techniques. C: The two arms of
split aptamer which was used in FRET to determine appropriateness of SSTA5 for SST. C1:Nucleotides in FAMSSTA5-5. Contains the addition of the single isomer, 6-FAM: an amine derivative of fluorescein (FAM) fluorophore,
on the 5’ end of SSTA5. C2: Nucleotides in TAMRA-SSTA5-3. Contains a covalently attached TAMRA to the 3’ end of
SSTA5: TAMRA (Tetramethylrhodamine) is a widely used fluorophore addition. D: Sequences for Fluorescence of
Auramine-O detection method. DAP signifies Dapoxyl, since dapoxyl aptamers have been recently discovered to be
able to cause auramine-O to become fluorescent (data not shown); S means Somatostatin, the first number
represents the version of the dapoxyl stem and the second number represents which arm of SSTA5 that it was built
on (5’ or 3’). E: G-quadruplex formation assay sequences, used for colorimetric readout. GU signifies G-quadruplex;
S stands for Somatostatin; the first number represents the version; and the second number was chosen based on
the original SSTA5 arm that it was built upon. F: Nucleotides in DAP-10, a positive control used in detection
technique 1. G: Nucleotides in PW17, a positive control used in detection technique 2.
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